Health Happening to focus on hypertension Oct. 24
The School of Medicine is hosting free blood pressure screenings at a mini Health Happening ’08 to be held Friday, Oct. 24.
Gordon, Holtzman elected to Institute of Medicine
Two faculty members at the School of Medicine have been elected to the Institute of Medicine of the National Academy of Sciences, one of the highest honors medical scientists in the United States can receive. Jeffrey Gordon and David Holtzman were recognized for their major contributions to the advancement of the medical sciences, health care and public health and commitment to service.
Cause of vision loss in macular degeneration also plays role in diabetic retinopathy, other retinal diseases
Scientists at the School of Medicine have determined that the same factors play key roles in three different diseases that can lead to blindness. In age-related macular degeneration, diabetic retinopathy and retinopathy of prematurity, abnormal blood-vessel growth threatens vision. Reporting in the journal PLoS One, Washington University vision scientists say that although the mechanisms are a bit different, all three retinal diseases involve the same immune-system factors.
Treatment filters bad cholesterol out of blood
Diet and lifestyle changes, combined with medication, can lower the risk of heart attack and stroke in patients with high levels of so-called bad cholesterol. But some patients genetically predisposed to high levels of LDL (low-density lipoprotein) don’t respond well to drug therapy. Now physicians at the School of Medicine can help these patients with a technique called LDL aphersis.
Scientists adapt economics theory to trace brain’s information flow
Scientists have used a technique originally developed for economic study to become the first to overcome a significant challenge in brain research: determining the flow of information from one part of the brain to another. Researchers at the School of Medicine and Florida Atlantic University report the new capability in The Journal of Neuroscience. It will provide important insights into brain organization and function, advancing efforts to help patients recover from brain injuries and mental disorders.
Nearly scarless surgery removes gallbladder through bellybutton incision
In a first for the St. Louis region, surgeons at the School of Medicine are removing patients’ gallbladders using a single small incision in the bellybutton that leaves only a barely visible scar. Surgery to remove the gallbladder is one of the most common operations performed in the United States. More than 750,000 patients undergo the procedure each year, often due to the formation of gallstones that cause intense pain.
Study: Bird diversity lessens human exposure to West Nile Virus
When the red, red robin comes bob, bob bobbin’ along, think West Nile Virus (WNV).This one’s for the birds. A study by biologists at Washington University in St. Louis shows that the more diverse a bird population is in an area, the less chance humans have of exposure to West Nile Virus (WNV). Now, let’s hear it for the birds. “The bottom line is that where there are more bird species in your backyard, you have much lower risk of contracting West Nile fever,” said Brian Allan, doctoral candidate in biology in Arts & Sciences at Washington University in St. Louis.
Form of Crohn’s disease traced to disabled gut cells
Scientists report in this week’s Nature that they have linked the health of specialized gut immune cells to a gene associated with Crohn’s disease, an often debilitating and increasingly prevalent inflammatory bowel disorder. The link to immune cells intrigued researchers at the School of Medicine because they and others believe Crohn’s disease is caused by misdirected immune responses in the intestine that damage gut tissue.
Support needed for women, underrepresented minorities to pursue biomedical research careers
A new School of Medicine study shows who M.D./Ph.D. students are and which students we need to support in these programs.
Old, new therapies combine to tackle atherosclerosis
Futuristic nanotechnology has been teamed with a decades-old drug to beat atherosclerotic plaques in new School of Medicine research.
View More Stories